Biopolis at One-North is one of JTC’s key projects to boost the biomedical industry as Singapore’s next engine of economic growth. As the premier research hub for Biomedical Sciences, it hosts leading public and private biomedical research institutes and organisations, and anchors the development of the entire research and development (R&D) value chain of life sciences. This encompasses basic drug discovery, clinical development and medical technology research. The Biopolis comprises 5 phases, with JTC undertaking the development of Phase 1 in 2003. Subsequent phases were developed by private developers and companies such as Ascendas and Procter & Gamble.